arsenic trioxide has been researched along with Atherogenesis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fang, S; Hao, X; Li, H; Liang, C; Sun, B; Sun, S; Wan, X; Yu, B; Zhang, F; Zhang, Z; Zou, X | 1 |
Mann, KK; Molina, MF; Padovani, AM | 1 |
2 other study(ies) available for arsenic trioxide and Atherogenesis
Article | Year |
---|---|
Arsenic trioxide induces macrophage autophagy and atheroprotection by regulating ROS-dependent TFEB nuclear translocation and AKT/mTOR pathway.
Topics: Animals; Apoptosis; Arsenic Trioxide; Atherosclerosis; Autophagy; Cell Nucleus; Humans; Macrophages; Male; Mice; Proto-Oncogene Proteins c-akt; RAW 264.7 Cells; Reactive Oxygen Species; Signal Transduction; THP-1 Cells; TOR Serine-Threonine Kinases; Transfection | 2021 |
Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
Topics: Animals; Apolipoprotein A-I; Arsenic Trioxide; Arsenicals; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Binding Sites; Biological Transport; Chlorocebus aethiops; Cholesterol; Chromatin Immunoprecipitation; Co-Repressor Proteins; COS Cells; Cyclic AMP; DNA-Binding Proteins; Dose-Response Relationship, Drug; Humans; Liver X Receptors; Macrophages; Mice; Orphan Nuclear Receptors; Oxides; Promoter Regions, Genetic; Protein Multimerization; Retinoid X Receptor alpha; Retinoid X Receptor beta; RNA Interference; RNA, Messenger; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Transcriptional Activation; Transfection | 2010 |